BrightSpring Health Services Inc. (NASDAQ: BTSG) saw its shares surge over 7% in pre-market trading on Thursday, after the company reported better-than-expected revenue for the third quarter of 2024 and raised its full-year guidance.
For the quarter ended September 30, 2024, BrightSpring Health reported adjusted earnings of $0.11 per diluted share, missing analysts' estimates of $0.17 per share. However, the company's revenue for the quarter soared 28.8% year-over-year to $2.91 billion, surpassing analysts' expectations of $2.72 billion.
Based on the strong performance, BrightSpring Health increased its full-year 2024 revenue guidance to a range of $11.0 billion to $11.3 billion, up from its previous guidance of $10.45 billion to $10.9 billion. This upward revision in guidance appears to have fueled the pre-market rally in the company's shares, as investors welcomed the growth prospects.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。